SOLICITATION NOTICE
65 -- CYTOCENTRIFUGE GRAM SLIDE STAINER MODEL 7321 - N62645-10-T0172
- Notice Date
- 8/4/2010
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of the Navy, Bureau of Medicine and Surgery, NMLC, 693 Neiman Street, FT Detrick, Maryland, 21702-9203, United States
- ZIP Code
- 21702-9203
- Solicitation Number
- N462460182M011
- Archive Date
- 8/28/2010
- Point of Contact
- Jaime R. Belletto, Phone: 3016193020
- E-Mail Address
-
jaime.belletto@med.navy.mil
(jaime.belletto@med.navy.mil)
- Small Business Set-Aside
- N/A
- Description
- CYTOCENTRIGUGE, GRAM SLIDE STAINER, MODEL 7321 DEPARTMENT OF THE NAVY NAVAL MEDICAL LOGISTICS COMMAND ESSENTIAL CHARACTERISTICS The requirement is for one cytocentrifuge/gram slide stainer. The cytocentrifuge/gram slide stainer shall be applicable to microbiological specimens and capable of staining body fluids. Cytocentrifuge/gram slide stainer shall apply stain using atomizing spray nozzles. The cytocentrifuge/gram slide stainer shall use fresh reagent for each stain application to prevent cross-contamination. Cytocentrifuge/gram slide stainer shall be capable of performing cytocentrifugation with an 8 place sealed rotor. The unit shall fix, stain and dry up to 12 slides in 5 minutes. The unit shall have the capability of performing self-cleaning. The cytocentrifuge/gram slide stainer shall have at minimum 5 decolorizer settings for adjustment of thick or thin smears. The cytocentrifuge/gram slide stainer shall have a level sensor that warns the user when reagent level is low. The cytocentrifuge/gram slide stainer shall weigh less than 19 kg. The electrical requirements are 120V, 60 Hz. Regulatory Requirements: The system and all of the components, shall be compliant with the Food and Drug Administration (FDA) requirements to market and deliver medical products for use in the United States of America, even should delivery be requested outside of the United States. The claims made for the product shall comply with the regulations of the FDA with respect to products for marketing and delivery of a medical product for use in the United States of America, even should delivery be requested outside of the United States. The system shall be installed in compliance with OSHA requirements. Market Acceptance Criteria: N/A DEPARTMENT OF THE NAVY NAVAL MEDICAL LOGISTICS COMMAND EVALUATION CRITERIA The Naval Medical Logistics Command intends to negotiate with vendors on a full and open competition basis to procure cytocentrifuge/gram slide stainer on behalf of USNS Comfort. This will include the procurement of a cytocentrifuge/gram slide stainer to assess microbiological substances using atomizing spray nozzles that uses fresh reagent for each stain application and capable of performing cytocentrifugation with an 8 place sealed rotor. This upgrade will replace the existing outdated slide stainers onboard USNS Comfort. Technical proposals must include sufficiently detailed information to enable evaluation based on the four (4) factors listed below in order of decreasing priority: 1.) Equipment Factors; Conformance to Essential Characteristics and Standardization; 2.) Human Factors; a.) Simplicity; b.) Ease of Use; 3.) Quality; a.) Warranty; b.) Parts Availability; c.) Parts Cost; d.) Serviceability; 4.) Instruction Materials; a.) Operator’s Manual; b.) Maintenance Manual DEPARTMENT OF THE NAVY NAVAL MEDICAL LOGISTICS COMMAND FEDERAL BUSINESS OPPORTUNITIES (FEDBIZOPS) ANNOUNCEMENT DRAFT The Naval Medical Logistics Command intends to negotiate with vendors on an open competition basis to procure cytocentrifuge/gram slide stainer on behalf of the United States Navy. Offerors are required to forward proposal and technical documentation by [date]. The technical documentation will be compared to the essential minimum essential characteristics and the evaluation factors listed below. Essential Characteristics: The requirement is for: The cytocentrifuge/gram slide stainer shall be applicable to microbiological specimens and capable of staining body fluids. Cytocentrifuge/gram slide stainer shall apply stain using atomizing spray nozzles. The cytocentrifuge/gram slide stainer shall use fresh reagent for each stain application to prevent cross-contamination. Cytocentrifuge/gram slide stainer shall be capable of performing cytocentrifugation with an 8 place sealed rotor. The unit shall fix, stain and dry up to 12 slides in 5 minutes. The unit shall have the capability of performing self-cleaning. The cytocentrifuge/gram slide stainer shall have at minimum 5 decolorizer settings for adjustment of thick or thin smears. The cytocentrifuge/gram slide stainer shall have a level sensor that warns the user when reagent level is low. The cytocentrifuge/gram slide stainer shall weigh less than 19 kg. The electrical requirements are 120V, 60 Hz. Evaluation Factors: Technical proposals must include sufficiently detailed information to enable evaluation based on the four (4) factors listed below in order of decreasing priority: 1.) Equipment Factors; Conformance to Essential Characteristics and Standardization; 2.) Human Factors; a.) Simplicity; b.) Ease of Use; 3.) Quality; a.) Warranty; b.) Parts Availability; c.) Parts Cost; d.) Serviceability; 4.) Instruction Materials; a.) Operator’s Manual; b.) Maintenance Manual Regulatory Requirements: The system and all of the components, shall be compliant with the Food and Drug Administration (FDA) requirements to market and deliver medical products for use in the United States of America, even should delivery be requested outside of the United States. The claims made for the product shall comply with the regulations of the FDA with respect to products for marketing and delivery of a medical product for use in the United States of America, even should delivery be requested outside of the United States. The system shall be installed in compliance with OSHA requirements. Market Acceptance Criteria: N/A
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DON/BUMED/N62645/N462460182M011/listing.html)
- Place of Performance
- Address: BALTIMORE, Maryland, United States
- Record
- SN02228025-W 20100806/100804234530-c8a810573dff5eb0f81fd382986c8ccb (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |